K. H. Lee, MD, “Clinical effectiveness and safety of OROS® hydromorphone in breakthrough cancer pain treatment: A multicenter, prospective, open-label study in Korean patients”, J of Opioid Management, vol. 8, no. 4, pp. 243–252, Jul. 2012.